197 related articles for article (PubMed ID: 3905326)
1. [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
Gonska BD; Kreuzer H
Dtsch Med Wochenschr; 1985 Nov; 110(47):1812-6. PubMed ID: 3905326
[TBL] [Abstract][Full Text] [Related]
2. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
Verho M; Bückert C; Freude J; Jaeger S; Pahnke K
Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674
[TBL] [Abstract][Full Text] [Related]
3. Lack of effect of piretanide (a potassium-stable diuretic) on serum magnesium.
Verho M; Irmisch R; de Looze S; Rangoonwala B
Int J Clin Pharmacol Res; 1987; 7(6):433-42. PubMed ID: 3440634
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
Zawada ET
Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
[TBL] [Abstract][Full Text] [Related]
5. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
6. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
Verho M; Rangoonwala B; Dols W; Fratzer U; Kaczynski J; Mühlhäusler W
Eur J Clin Pharmacol; 1984; 27(4):407-14. PubMed ID: 6394349
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene.
Pörsti P; Jalonen K; Ryysy L; Toivonen T; Viherkoski M
Ann Clin Res; 1981 Feb; 13(1):6-10. PubMed ID: 7018363
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
[TBL] [Abstract][Full Text] [Related]
9. Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride.
Verho M; Bossaller W; Malerczyk V
Int J Clin Pharmacol Res; 1988; 8(1):5-8. PubMed ID: 3284831
[TBL] [Abstract][Full Text] [Related]
10. Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.
Verho M; Bossaller W; Heinen B
Int J Clin Pharmacol Res; 1987; 7(1):5-11. PubMed ID: 3294616
[TBL] [Abstract][Full Text] [Related]
11. Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
Verho M; Rangoonwala B; Beloso M; Maass L; Bender R; Garduno D
Drugs Exp Clin Res; 1986; 12(5):385-91. PubMed ID: 3522159
[TBL] [Abstract][Full Text] [Related]
12. [Serum and total body potassium during treatment with chlortalidone and hydrochlorothiazide. Influence of triamterene (author's transl)].
Schäfer GE; Werner E; Kober G; Kaltenbach M
Dtsch Med Wochenschr; 1977 Dec; 102(50):1838-43. PubMed ID: 590117
[TBL] [Abstract][Full Text] [Related]
13. Comparison of piretanide and chlorothiazide in the treatment of cardiac failure.
Gillies A; Morgan T; Myers J
Med J Aust; 1980 Feb; 1(4):170-2. PubMed ID: 6990212
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two combined diuretics in the treatment of essential hypertension.
Verhiest W; Baehre M; Volkers P
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
[TBL] [Abstract][Full Text] [Related]
15. A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure.
Ghosh AK; Mankikar G; Strouthidis T; Windsor A; Long C; Glover DR
Curr Med Res Opin; 1987; 10(9):573-9. PubMed ID: 3436153
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of triamterene and hydrochlorothiazide and their combination in healthy volunteers.
Möhrke W; Knauf H; Mutschler E
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):447-52. PubMed ID: 9352394
[TBL] [Abstract][Full Text] [Related]
17. Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
McNabb WR; Noormohamed FH; Lant AF
Br J Clin Pharmacol; 1988 Aug; 26(2):143-54. PubMed ID: 3207551
[TBL] [Abstract][Full Text] [Related]
18. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
Woo J; Woo KS; Kin T; Vallance-Owen J
Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of diuretics in congestive heart failure. A detailed study in four patients.
Mahabir RN; Laufer ST
Arch Intern Med; 1969 Jul; 124(1):1-7. PubMed ID: 5791481
[No Abstract] [Full Text] [Related]
20. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
